Title:
Association between an Isothiocyanate and Levodopa in the treatment of Parkinson's disease
Location:Italy
Ref no:09 IT 54V8 3FQ5
Rating:
Abstract
An Italian University research laboratory has developed a method that could ameliorate the ratio risk/benefit associated with Levodopa (1-3,4-diidrossifenilalanina) or L-DOPA therapy in the symptomatic treatment of Parkinson's disease (PD), and could prevent and delay the neurodegenerative process induced by L-DOPA. They are looking for license agreement and industrial development.
Details
>> To find out more about the opportunity login or register for C2i.
|